JPRN-UMIN000009224
Completed
未知
Transcatheter aortic valve replacement for patients with aortic valve stenosis - Transcatheter aortic valve replacement
Kurashiki Central Hospital Department of Cardiology Department of Cardiovascular Surgery0 sites20 target enrollmentNovember 1, 2012
ConditionsSevere aortic valve stenosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Severe aortic valve stenosis
- Sponsor
- Kurashiki Central Hospital Department of Cardiology Department of Cardiovascular Surgery
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Acute myocardial infarction within 1 month 2\. Unicuspid, bicuspid aortic valve, or aortic valve stenosis without calcification 3\. Severe aortic valve regurgitation 4\. Cardiac intervention within 2 weeks 5\. Prior valve surgery with artifical valve ring or severe mitral valve regurgitation with level 3 or 4 6\. Leukopenia, acute anemia, thrombocytopenic purpura, or past history of coagulation disorder 7\. Coronary artery disease with significant stenosis requiring intervention. 8\. Unstable circulation requiring mechanical support 9\. Emergency procedure 10\. Obstructive or nonobstructive cardiomyopathy 11\. Severe LV dysfunction (LVEF\<20%) 12\. Cardiac tumor, thrombus, vegetation in UCG 13\. Active gastrointestinal ulcer or history of upper gastrointestinal bleeding within 3 months 14\. Allergy to aspirin, heparin, ticropigin, or contrast medium 15\. Aortic valve annulus smaller than 16 mm or larger than 25 mm 16\. CVA or TIA within 1 month 17\. Life expectancy less than 12 months due to non\-cardiac disease 18\. Involvement in another clinical trial 19\. Active bacterial endocarditis or other active infections 20\. Massive calcified cusp of aortic valve close to the coronary ostium 21\. Allergy to cobalt\-chromium alloy 22\. Abdominal or thoracic aortic aneurysm or atheroma (diameters more than 5 cm ), and serious denaturation or anatomical features of thoracoabdominal aorta 23\. Severe calcification, extreme tortuosity and vessel diameter less than 6\.5 mm making the safe insertion of sheath introducer impossible from the common iliac artery through the femoral artery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-upsevere aortic valve stenosis10046973NL-OMON45149Medtronic B.V.160
Recruiting
Phase 3
Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure: a randomized trial (TAVR-UNLOAD)aorta stenoseheart failuremoderate aortic stenosis10019280NL-OMON54518Cardiovascular Research Foundation (CRF)56
Completed
Not Applicable
Transcatheter aortic valve implantation for aortic stenosis registryAortic stenosisJPRN-UMIN000023705Keio University Hospital800
Terminated
Not Applicable
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Regurgitation, Pilot studyDiseases of the circulatory systemKCT0003085Asan Medical Center2
Recruiting
Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve ReplacementNL-OMON53079Medtronic B.V.60